{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:31:51Z","timestamp":1790332311960,"version":"4.1.0"},"reference-count":60,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Many patients living with human immunodeficiency virus (HIV) may develop long-term metabolic complications due to various reasons, such as chronic inflammation and adverse effects from antiretrovirals (ARVs). A particularly significant metabolic complication is type 2 diabetes (T2DM); however, limited evidence is available regarding the management of this disease state among people living with HIV (PLWH). We review the available resources and evidence on the management of T2DM among PLWH. Diagnosis and monitoring of T2DM are slightly different from the general population as hemoglobin A1c may underestimate the level of glycemia PLWH experience. Although PLWH are typically not reported within landmark clinical trials for antidiabetic medications, treatment is likely similar to those without the virus. There are several drug-drug interactions to note between ARVs and antidiabetic medications with one of the most notable being between dolutegravir and metformin. This interaction requires the maximum daily dose of metformin to be reduced. Additionally, modifications may be considered to a patient\u2019s ARV regimen in order to reduce metabolic disturbances as these medications may affect fat redistribution, lipids, weight, and insulin resistance. This review article is intended to aide clinicians in clinical decision making when treating PLWH diagnosed with T2DM.<\/jats:p>","DOI":"10.1177\/08971900251394121","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T20:02:48Z","timestamp":1763496168000},"page":"355-366","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Intersecting Burdens: Type 2 Diabetes Diagnosis, Risk, and Pharmacological Management Among People Living With HIV"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4431-8666","authenticated-orcid":false,"given":"Rachel","family":"Arnold","sequence":"first","affiliation":[{"name":"The Brooklyn Hospital Center (Pharmacy Department)"},{"name":"Long Island University (LIU Pharmacy)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3758-0590","authenticated-orcid":false,"given":"Briann","family":"Fischetti","sequence":"additional","affiliation":[{"name":"The Brooklyn Hospital Center (Pharmacy Department)"},{"name":"Long Island University (LIU Pharmacy)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3394-7033","authenticated-orcid":false,"given":"Maria","family":"Longo","sequence":"additional","affiliation":[{"name":"The Brooklyn Hospital Center (Pharmacy Department)"},{"name":"Long Island University (LIU Pharmacy)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"U.S. statistics. HIV.gov. Accessed May 18 2025.https:\/\/www.hiv.gov\/hiv-basics\/overview\/data-and-trends\/statistics"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001014"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/v14010122"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1082992"},{"issue":"8","key":"e_1_3_4_6_2","first-page":"e43909","article-title":"Exploring the relation between diabetes and HIV: a narrative review","volume":"15","author":"Kumar M","year":"2023","unstructured":"Kumar M, Singh H, Chakole S. Exploring the relation between diabetes and HIV: a narrative review. Cureus. 2023;15(8):e43909.","journal-title":"Cureus"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S002"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0177"},{"key":"e_1_3_4_9_2","unstructured":"EAG\/A1C conversion calculator. eAG\/A1C Conversion Calculator | American Diabetes Association."},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S009"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.472"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2007.00488.x"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-05968-7"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24540"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/idr15030024"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000983"},{"key":"e_1_3_4_17_2","volume-title":"StatPearls. Treasure Island (FL)","author":"Collins L","unstructured":"Collins L, Costello RA. Glucagon-Like Peptide-1 Receptor Agonists. In:StatPearls. Treasure Island (FL): StatPearls Publishing. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551568\/"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603827"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61246-5"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1607141"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)001741"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa19011181"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2501006"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31149-32"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa21075191"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa15047201"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa18123891"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa16119251"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003791"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/M23-3354"},{"key":"e_1_3_4_31_2","unstructured":"Rybelsus. Package Insert. Novo nordisk; 2024."},{"key":"e_1_3_4_32_2","volume-title":"Liverpool Drug Interactions Group","author":"Rilpivirine - atazanavir - semaglutide","unstructured":"Rilpivirine - atazanavir - semaglutide. Interactions. HIV drug interactions. In: Liverpool Drug Interactions Group. https:\/\/www.hiv-druginteractions.org\/. Accessed May 6, 2024."},{"key":"e_1_3_4_33_2","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of health and human services. Year. [Appendix B: Drug Characteristics Tables]. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv. Accessed May 6 2024."},{"key":"e_1_3_4_34_2","volume-title":"StatPearls","author":"Kasina SVSK","year":"2024","unstructured":"Kasina SVSK, Baradhi KM. Dipeptidyl Peptidase IV (DPP IV) Inhibitors. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542331\/"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3532"},{"key":"e_1_3_4_36_2","unstructured":"HIV Drug Interactions. Liverpool drug interactions group. https:\/\/www.hiv-druginteractions.org\/. Accessed May 6 2024."},{"key":"e_1_3_4_37_2","volume-title":"StatPearls","author":"Padda IS","year":"2024","unstructured":"Padda IS, Mahtani AU, Parmar M. Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576405\/"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2017.03.002"},{"key":"e_1_3_4_39_2","first-page":"453","article-title":"Diagnosing and managing diabetes in HIV-Infected patients: current concepts","volume":"60","author":"Monroe A","year":"2015","unstructured":"Monroe A, Glesby MJ, Brown TT. Diagnosing and managing diabetes in HIV-Infected patients: current concepts. HIV\/AIDS CID. 2015;60:453-462.","journal-title":"HIV\/AIDS CID"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003227"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1080\/17571472.2017.1302872"},{"key":"e_1_3_4_42_2","unstructured":"Thota S Akbar A Insulin. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560688\/"},{"key":"e_1_3_4_43_2","unstructured":"Insulin resistance in HIV infection: drugs host responses or restoration to health? International AIDS Society\u2013USA. 2008. Accessed April 19 2024.https:\/\/www.iasusa.org\/"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07485-1"},{"key":"e_1_3_4_45_2","volume-title":"StatPearls","author":"Freeman AM","year":"2024","unstructured":"Freeman AM, Acevedo LA, Pennings N. Insulin Resistance. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507839\/"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.2337\/db18-1577-P"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18372"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.10.1180"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0718"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350801300107"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.4137\/CMED.S19202"},{"key":"e_1_3_4_52_2","volume-title":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2023","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services, 2023."},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902824"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae449"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002642"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.70061"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06479-9"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304146"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462417732226"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac355"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002699"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08971900251394121","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08971900251394121","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08971900251394121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:56:50Z","timestamp":1782532610000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08971900251394121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/08971900251394121"],"URL":"https:\/\/doi.org\/10.1177\/08971900251394121","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]}}}